Navigation Links
Investigation to Show Harassment, Legal Restrictions Impose Severe Obstacles for Abortion Providers and Women Seeking Abortions
Date:7/13/2009

NEW YORK, July 13 /PRNewswire-USNewswire/ -- Next week, the Center for Reproductive Rights will release the results of an investigation of abortion clinics in six states demonstrating that attacks, harassment, discriminatory legal restrictions and stigma are causing a shortage of abortion facilities and providers, severely limiting women's reproductive rights. The report will be released at a briefing for members of Congress, staff and media on Wednesday, July 22, at 12:30 p.m. in room HC-8 of the U.S. Capitol.

The report -- which studied clinics in Alabama, Mississippi, Missouri, North Dakota, Pennsylvania and Texas -- calls for urgent action by governments at all levels, law enforcement, the medical community and the public to recognize abortion providers as human rights defenders who protect women's fundamental rights.

WHAT: Congressional Briefing: Defending Human Rights: Abortion Providers Facing Threats, Restrictions and Harassment

WHO: Rep. Jerrold Nadler (D-NY)

Rep. Jan Schakowsky (D-IL)

Nancy Northup, Center for Reproductive Rights

Marianne Mollman, Human Rights Watch

Amy Hagstrom Miller, Whole Woman's Health

WHEN: 12:30 p.m. - 2:00 p.m., Wednesday, July 22, 2009

WHERE: Room HC - 8 US Capitol

The Center for Reproductive Rights is a global legal organization dedicated to advancing women's reproductive health, self-determination and dignity as basic human rights.


'/>"/>
SOURCE Center for Reproductive Rights
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
3. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
8. UGA vet school receives $1.18 million NIH grant for rabies vaccine investigations
9. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
10. Accentia announces investigational new drug application for Revimmune for refractory MS
11. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 29, 2017 , ... Dr. Isabella Wentz, ... launching a 9-part video series titled The Thyroid Secret. Dr. Wentz talked about journey ... which emphasizes the fact that medication IS NOT the only solution to deal with ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 This morning,s research ... stocks: The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals ... and Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ... space which is governed by the same governing ... the industry are wholesalers, retailers, pharmacies, and benefit ...
(Date:3/28/2017)... , March 28, 2017 RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Japan Patent Office (JPO) for the ... growth factor (CTGF) for the treatment or prevention ... skin fibrosis and proliferative retinopathy (Japanese Patent #: ...
(Date:3/27/2017)... March 27, 2017 The National University ... and data analytics company, signed a Memorandum of ... healthcare delivery in the region. ... Health Research and Technology (BIGHEART) at NUS and ... topics related to healthcare IT and medical device ...
Breaking Medicine Technology: